Treatment Progress for EGFR Wild-type Advanced Non-small Cell Lung Cancer

Lung cancer is the leading cause of death from cancer in the world. The treatment remains one of the most challenging tasks in the medical world. The discovery and development of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) have had a major impact in the treatment of non sma...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Feng MA, Xiaoyu SHI, Wei MENG, Jing ZHANG, Lixia ZHAO, Xiaohua HE, Junfeng ZHAO
Format: Artigo
Jezik:Chinês
Izdano: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-07-01
Serija:Chinese Journal of Lung Cancer
Teme:
Lung neoplasms
Epidermal growth factor receptor
Wild type
Chemotherapy
Targeted therapy
Maintenance treatment
Online dostop:http://dx.doi.org/10.3779/j.issn.1009-3419.2014.07.14
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki